LETTER TO THE EDITOR
Factor VIII products and inhibitor development: concepts for revision of European regulatory guidelines
Article first published online: 7 DEC 2007
Volume 14, Issue 1, pages 142–144, January 2008
How to Cite
NEUGEBAUER, B., DRAI, C., HAASE, M., HILGER, A., KELLER-STANISLAWSKI, B., LAITINEN-PARKKONEN, P., MENTZER, D., RASMUSSEN, C., RATIGNIER, C. and SEITZ, R. (2008), Factor VIII products and inhibitor development: concepts for revision of European regulatory guidelines. Haemophilia, 14: 142–144. doi: 10.1111/j.1365-2516.2007.01604.x
- Issue published online: 7 DEC 2007
- Article first published online: 7 DEC 2007
- Accepted after revision 17 October 2007
Options for accessing this content:
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!